IE44950B1 - Improvements in or relating to spirocyclic compounds - Google Patents

Improvements in or relating to spirocyclic compounds

Info

Publication number
IE44950B1
IE44950B1 IE971/77A IE97177A IE44950B1 IE 44950 B1 IE44950 B1 IE 44950B1 IE 971/77 A IE971/77 A IE 971/77A IE 97177 A IE97177 A IE 97177A IE 44950 B1 IE44950 B1 IE 44950B1
Authority
IE
Ireland
Prior art keywords
compound
carbon atoms
formula
alkyl
hydrogen
Prior art date
Application number
IE971/77A
Other languages
English (en)
Other versions
IE44950L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE44950L publication Critical patent/IE44950L/xx
Publication of IE44950B1 publication Critical patent/IE44950B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE971/77A 1976-05-14 1977-05-12 Improvements in or relating to spirocyclic compounds IE44950B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH606376A CH621330A5 (2) 1976-05-14 1976-05-14

Publications (2)

Publication Number Publication Date
IE44950L IE44950L (en) 1977-11-14
IE44950B1 true IE44950B1 (en) 1982-05-19

Family

ID=4303639

Family Applications (1)

Application Number Title Priority Date Filing Date
IE971/77A IE44950B1 (en) 1976-05-14 1977-05-12 Improvements in or relating to spirocyclic compounds

Country Status (26)

Country Link
US (1) US4322437A (2)
JP (1) JPS52139051A (2)
AT (1) AT362349B (2)
AU (1) AU513066B2 (2)
BE (1) BE854567A (2)
CA (1) CA1095913A (2)
CH (1) CH621330A5 (2)
CY (1) CY1226A (2)
DE (1) DE2719871A1 (2)
DK (1) DK197677A (2)
ES (1) ES458724A1 (2)
FI (1) FI771427A7 (2)
FR (1) FR2351091A1 (2)
GB (1) GB1576034A (2)
HK (1) HK35984A (2)
IE (1) IE44950B1 (2)
IL (1) IL52072A (2)
KE (1) KE3405A (2)
NL (1) NL7705128A (2)
NZ (1) NZ184079A (2)
PH (1) PH14176A (2)
PT (1) PT66540B (2)
SE (1) SE7705221L (2)
SG (1) SG84983G (2)
SU (1) SU634663A3 (2)
ZA (1) ZA772873B (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2810869A1 (de) * 1977-03-24 1978-09-28 Sandoz Ag 3-amino-2-hydroxypropoxy-derivate, ihre herstellung und verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641152A (en) * 1949-07-15 1953-06-09 Herbert M Hise Stringed musical instrument
GB1046001A (en) * 1964-03-12 1966-10-19 Ici Ltd Propanolamine derivatives
US3839415A (en) * 1965-10-22 1974-10-01 Lilly Co Eli 2-halo-1-(alkyl-1-(alkylamino)ethyl)vinyl benzoic acid esters and derivatives
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
CH554314A (de) * 1969-06-03 1974-09-30 Sandoz Ag Verfahren zur herstellung neuer fluorenone.
BE755071A (fr) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Also Published As

Publication number Publication date
BE854567A (fr) 1977-11-14
FR2351091B1 (2) 1980-01-18
PH14176A (en) 1981-03-19
HK35984A (en) 1984-05-04
PT66540B (fr) 1979-10-22
DE2719871A1 (de) 1977-12-01
ZA772873B (en) 1978-12-27
IE44950L (en) 1977-11-14
ES458724A1 (es) 1978-08-01
KE3405A (en) 1985-02-01
CY1226A (en) 1984-04-06
CH621330A5 (2) 1981-01-30
SG84983G (en) 1985-01-11
SU634663A3 (ru) 1978-11-25
AT362349B (de) 1981-05-11
ATA343577A (de) 1980-10-15
NL7705128A (nl) 1977-11-16
IL52072A0 (en) 1977-07-31
NZ184079A (en) 1978-09-25
SE7705221L (sv) 1977-11-15
FR2351091A1 (fr) 1977-12-09
DK197677A (da) 1977-11-15
US4322437A (en) 1982-03-30
CA1095913A (en) 1981-02-17
AU513066B2 (en) 1980-11-13
JPS52139051A (en) 1977-11-19
IL52072A (en) 1980-10-26
AU2514077A (en) 1978-11-16
GB1576034A (en) 1980-10-01
FI771427A7 (2) 1977-11-15
PT66540A (fr) 1977-06-01

Similar Documents

Publication Publication Date Title
EP0025111B1 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
US4261895A (en) Alkanoyl-proline derivatives and homologues thereof
US4234584A (en) Substituted phenylpiperazine derivatives
US4751230A (en) 2,3-dihydrobenzofuran compounds, composition and their method of use
US3699123A (en) 4-(3-amino-2-hydroxy-propoxy) indole derivatives
US3825558A (en) Substituted aminopropoxy-2-indolinones
CA1098909A (en) Indolyloxy-aminopropanol derivatives
FI77224C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara aminopropanolderivat av 2-hydroxi- -fenylpropiofenoner.
US4235919A (en) 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
US4935414A (en) New indolylpropanols, processes for their preparation and their use, and preparations containing the compounds
US4395559A (en) 2,3-Indoledione derivatives
US4977153A (en) 3-aminopropyloxyphenyl derivatives, pharmaceutical compositions containing them and method for the therapy of diseases
US3751429A (en) 4-(3-amino-2-substituted propoxy)indole derivatives
US4272533A (en) N-Phenylindoline derivatives, and pharmaceutical compositions containing them
US4791108A (en) Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers
US4080463A (en) 2-Substituted-aminopropoxy indoles
IE43797B1 (en) Esters of indole-derived amino alcohols
CH662354A5 (fr) Derives de l'hydantoine, procede pour leur preparation et medicament contenant ces derives.
CA1095913A (en) 3-amino-2-hydroxypropoxyphenyl derivatives
US3696121A (en) 4-(2-hydroxy-3-amino propoxy)-indole derivatives
US3898224A (en) 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US4885299A (en) 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acids antihypoxic and nootropic effects having
US4411913A (en) 8'-[(3-Amino-2-hydroxy-propoxy)]-spiro-[cyclopentane-1,2'(1'H)-(3'H)naphtalen]-4'(3'H)-ones
EP0002792A1 (en) 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
US3758502A (en) Organic compounds